Effect of HER2 status on distant recurrence in early stage breast cancer
- 6 December 2012
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 137 (2), 449-455
- https://doi.org/10.1007/s10549-012-2366-0
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtypeBreast Cancer Research and Treatment, 2012
- Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survivalBritish Journal of Cancer, 2012
- The landscape of cancer genes and mutational processes in breast cancerNature, 2012
- Adjuvant Trastuzumab in HER2-Positive Breast CancerNew England Journal of Medicine, 2011
- Defining prognosis for women with breast cancer and CNS metastases by HER2 statusAnnals Of Oncology, 2008
- Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)Annals of Oncology, 2006
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerNew England Journal of Medicine, 2005
- Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinomaCancer, 2003
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999